In a photo taken a few hours ago at the NATO summit in Vilnius, Lithuania, leaders of the Western

world stand together on a stage.

Ukraine's president, Volodymyr Zelensky, is not in that picture.

He'd really like to be, but NATO has not invited Ukraine to join yet.

Zelensky is on his way to the summit anyway.

He tweeted today that it is unprecedented and absurd that Ukraine hasn't been given a timeline

for when it may be able to join NATO.

And he ended saying this, uncertainty is weakness and I will openly discuss this at the summit.

Even without the vow of verbal confrontation, all lies were going to be on Zelensky.

Russia's invasion of his country is forcing the NATO alliance over the next two days.

To confront how far it's going to go to help Ukraine.

Some things, immediate membership, are off the table.

Others, including a catastrophically dangerous weapon, are suddenly in play.

So ahead, on today's point.

GSK believes innovation starts when you stop to listen.

That's why GSK and Veeve Health Care have partnered with the HIV community for decades

and developed medicines that better fit the lives of people living with HIV.

That's just one example of how GSK unites science, technology and talent to get ahead

of disease together.

Visit GSK.com to learn more.

It's today explained, Felicia Schwartz is the US foreign affairs and defense correspondent

for the Financial Times.

...